See Remarks · AN2 Therapeutics, Inc. · Common Stock
Side
SELL
Value
$12K
Shares
2,826
Price
$4.22
Executed
Nov 5, 2026
Disclosed
Nov 6, 2026
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Nov 5 executedNov 6, 2026 disclosed
ANTX · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Other disclosed activity · ANTX
No records
No other disclosures for this security in the dataset.
Evidence
Verified data
Read directly from the primary public document; every field below is as reported by the filer.
Eizen Joshua M filed this Form 4 reporting a open-market sale of ANTX on Nov 5, 2026. It became public on Nov 6, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
See Remarks
Eizen Joshua Mcik:0001949621
Issuer
AN2 Therapeutics, Inc.cik:0001880438
Revision history · 0
No field has changed since this record was first ingested.
